SCHEMBL4459295

SCHEMBL4459295

[CH2][CH]n1cnc2cccc(C(F)(F)F)c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.38
▸ PRPS1 P60891 1/20 0.37
▸ HCAR1 Q9BXC0 2/20 0.35
▸ AR P10275 1/20 0.34
▸ EPHX2 P34913 1/20 0.32
▸ KCNH2 Q12809 3/20 0.32
▸ GRM2 Q14416 3/20 0.32
▸ ESR1 P03372 2/20 0.32
▸ TDP1 Q9NUW8 2/20 0.31
▸ CYP1A2 P05177 2/20 0.31
▸ FGFR1 P11362 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31698451 0.72 ESR1 (0.41) POLBPRPS1HCAR1ARESR1
SCHEMBL27625206 0.69 AR (0.40) POLBPRPS1HCAR1ARESR1
SCHEMBL25922298 0.69 PRPS1 (0.41) POLBPRPS1HCAR1ARKCNH2
SCHEMBL3037828 0.67 AR (0.47) POLBPRPS1ARLMNACYP3A4
SCHEMBL30317200 0.65 JAK1 (0.47) PRPS1EPHX2CYP1A2MAPK1CYP2C19
SCHEMBL31415669 0.63 AR (0.43) POLBPRPS1ARKCNH2GRM2
SCHEMBL24346878 0.62 POLB (0.39) POLBPRPS1HCAR1CYP1A2FGFR1
SCHEMBL937961 0.60 HCAR1 (0.34) POLBPRPS1HCAR1AREPHX2
SCHEMBL19678220 0.60 POLB (0.50) POLBHCAR1KCNH2ALDH1A1
SCHEMBL7811170 0.60 HSD11B1 (0.38) PRPS1KCNH2GRM2ESR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2042490-A2 Benzimidazole derivatives as vanilloid receptor antagonists AstraZeneca AB (SE) 2009-04-01 — — EP disclosed
Send feedback